Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Liberty Health Sciences Inc SCQBD

Liberty Health Sciences Inc is committed to delivering pharmaceutical-grade cannabis to patients. The company produces pharmaceutical-grade marijuana. It operates in the United States and Canada. The company generated most of its revenue from dispensary customers.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (OTCPK:SCQBD)

Major Cannabis Player Sees Florida Sales Surge ...

Streetwise Reports April 17, 2018

2017: A year of triple digit stock performance

Streetwise Reports January 3, 2018

Cannabis biotech stock starting to advance again

Streetwise Reports December 18, 2017

Bullboard Posts (OTCPK:SCQBD)

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
Namiii - July 14, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Namiii - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Namiii - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Namiii - May 10, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
Namiii - May 1, 2022

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

 
Namiii - April 24, 2022